Biofrontera Inc.
BFRI
Rangering i aksjer
#31612
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization... Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Aksjekurs
$0.8024
Markedsverdi
$11.92M
Endring (1 dag)
-0.20%
Endring (1 år)
-72.80%
Land
US
Handel Biofrontera Inc. (BFRI)
Kategori
Healthcare
Aksjeprishistorikk for Biofrontera Inc. (BFRI)
Høyeste sluttskurs: $2.93 den 2024-06-01
Laveste sluttskurs: $328.16 den 2006-10-01
Laveste sluttskurs: $328.16 den 2006-10-01
Aksjeprishistorikk for Biofrontera Inc. fra 2006 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2024 | -73.04% |
| 2023 | -68.52% |
| 2022 | -5.85% |
| 2021 | -48.56% |
| 2020 | -30.24% |
| 2019 | -15.14% |
| 2018 | 34.15% |
| 2017 | 41.58% |
| 2016 | 70.60% |
| 2015 | -31.22% |
| 2014 | -36.74% |
| 2013 | -4.76% |
| 2012 | 28.04% |
| 2011 | 56.02% |
| 2010 | -25.62% |
| 2009 | 48.88% |
| 2008 | -87.41% |
| 2007 | -3.58% |
| 2006 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $62.44 | 66.60% |
US
|
|
| $46.29 | 38.28% |
SE
|
|
| $171.04 | 30.37% |
FR
|
|
| $117.04 | 55.24% |
US
|
|
| $59.46 | 0.32% |
IT
|
